ClinicalTrialsFinder
RecruitingPhase 1Phase 2NCT06532253

Long-term Safety Trial with NVDX3

Long-term Safety Bucket Trial with NVDX3, an Osteogenic Implant of Human Allogenic Origin.

Sponsor

Novadip Biosciences

Enrollment

15 participants

Start Date

Aug 22, 2024

Study Type

INTERVENTIONAL

Conditions

Distal Radius FracturesDegenerative Lumbar Spondylolisthesis

Summary

An study evaluating the long-term safety of all patients previously treated with NVDX3.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called NVDX3 for people with degenerative lumbar spondylolisthesis and distal radius fractures. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNVDX3

NVDX3 is implanted during a single surgical intervention, that took place in the core trials (refer to NCT05961956 and NCT05987033)

Locations(1)

Centre Hospitalier de Luxembourg

Luxembourg, Luxembourg

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06532253

Related Trials

Impact of Early ADL Education on Outcomes Post DRF ORIF

NCT062512061 location

Radiological Criteria for Instability in Distal Radius Fractures

NCT066177801 location

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

NCT063844561 location

Prednisone for CRPS in Distal Radius Fracture

NCT064534471 location

Comparative Study Between Cannulated Screws and K-wires in the Fixation of Distal Radius Fractures

NCT075233861 location